Author

Zahraa Zibara

Observed name: Zibara, Zahraa

Institutions: One Percent Research Initiative, Lebanese American University

Observed institutions: One Percent Research Initiative, Lebanese American University

ORCID: 0009-0004-9111-3955

Observed ORCID: 0009-0004-9111-3955

OpenAlex ID: A5115942729

Potential therapeutic applications of medical gases in cancer treatment

2025 · Abbas Al Bazzal, Bassel H. Hoteit, et al. · Medical Gas Research · 19

Optimizing plasmonic photothermal therapy a numerical study on tissue specific thermal and optical properties for cancer treatment

2025 · Omar Eladarousy, Zahraa Zibara, et al. · Scientific Reports · 10

Global and regional progress towards reduced burden of oral conditions between 2019 and 2023: a systematic analysis for the Global Burden of Disease Study 2023

2026 · Eduardo Bernabe, Wagner Marcenes, et al. · The Lancet Public Health · 3

Negative Pressure Wound Therapy Versus Standard Dressings for Preventing Surgical Site Infections Following Abdominal Surgery: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

2026 · AlMothana Manasrah, Alaa Ayyad, et al. · World Journal of Surgery · 2

Public perceptions of mortality studies in conflict-affected areas of the Eastern Mediterranean Region: an exploratory study

2026 · Esra Abdallah Abdalwahed Mahgoub, Ali Alshalah, et al. · Conflict and Health · 1

Halzoun syndrome in Lebanon: Clinical and genetic insights into Dicrocoelium dendriticum

2025 · Dalal Sabbagh, Ahmad El Khatib, et al. · Tropical Medicine & International Health · 1

Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

2025 · Lynn Al Samra, Mohamad El Nahas, et al. · Parasite · 1

Quantitative analysis of thermal dynamics in gold nanorods, laser and concentration effects with relevance to cancer therapy

2026 · Nissrine Al Helou, Iman Alwan, et al. · Results in Optics

Persistent thrombocytosis in β-thalassemia post-splenectomy: A STROBE-compliant retrospective cohort study at a Jordanian referral center

2026 · Aisheh Alesufi, Naser Aldain A. Abu Lehyah, et al. · Medicine

Public perceptions of mortality studies in conflict-affected areas of the Eastern Mediterranean Region: an exploratory study

2026 · Esra Abdallah Abdalwahed Mahgoub, Ali Alshalah, et al. · Figshare

Additional file 3 of Public perceptions of mortality studies in conflict-affected areas of the Eastern Mediterranean Region: an exploratory study

2026 · Esra Abdallah Abdalwahed Mahgoub, Ali Alshalah, et al. · Figshare

Additional file 2 of Public perceptions of mortality studies in conflict-affected areas of the Eastern Mediterranean Region: an exploratory study

2026 · Esra Abdallah Abdalwahed Mahgoub, Ali Alshalah, et al. · Figshare

Additional file 1 of Public perceptions of mortality studies in conflict-affected areas of the Eastern Mediterranean Region: an exploratory study

2026 · Esra Abdallah Abdalwahed Mahgoub, Ali Alshalah, et al. · Figshare

Knowledge and attitudes toward mpox among the Lebanese population during the second wave and their attitudes toward vaccination

2026 · Mohammad Tanashat, Nour Fakih, et al. · Scientific Reports

Figure 1 in Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

2025 · Samra, Lynn Al, Nahas, Mohamad El, et al. · Zenodo (CERN European Organization for Nuclear Research)

Figure 2 in Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

2025 · Samra, Lynn Al, Nahas, Mohamad El, et al. · Zenodo (CERN European Organization for Nuclear Research)

Figure 3 in Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

2025 · Samra, Lynn Al, Nahas, Mohamad El, et al. · Zenodo (CERN European Organization for Nuclear Research)

Figure 5 in Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

2025 · Samra, Lynn Al, Nahas, Mohamad El, et al. · Zenodo (CERN European Organization for Nuclear Research)

Figure 4 in Repositioning of moxidectin: a promising approach in cutaneous leishmaniasis therapy

2025 · Samra, Lynn Al, Nahas, Mohamad El, et al. · Zenodo (CERN European Organization for Nuclear Research)

Works count: 19

Citation count: 37

H-index: 3

I10-index: 2